Egg Donation: A Victory for Reproductive Justice or Another Handmaid’s Tale?
By Chantal Bittner,
Bill of Health
| 02. 04. 2025
Before the United States election in 2024, Margaret Atwood shared a cartoon illustrating the handmaids from her dystopian novel entering a polling booth in their unmistakable red cloaks and white bonnets. Having voted, they transform into unique individuals, discarding the attire symbolizing their reproductive enslavement.
One of the central topics of the election campaign was undoubtedly abortion—a key issue in the fight for reproductive justice. However, reproductive justice encompasses far more than abortion. The egg donation industry has expanded into a multi-billion dollar market. While altruism frequently frames their actions, financial incentives are central to attracting many young women to donate—really, sell—their eggs. Upon closer examination, egg donors play a subordinate role despite being essential for the market to function. This post explores the egg market in the U.S. and Europe, shedding light on its implications for the reproductive rights of third parties involved in the process.
The U.S.: A free market model
In the U.S., egg donation operates as an unregulated free market. Compensation varies widely, reaching up to $250,000 in exceptional cases, with an average payment of approximately $7,000. Efforts by the American Society for Reproductive Medicine (ASRM) to regulate this market through guidelines capping payments failed: ASRM attempted to limit donor remuneration to $10,000. However, two donors sued ASRM, claiming the guidelines violated U.S. antitrust laws by constituting price-fixing. In 2015...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...